Liu Xuerong, Wang Yan, Zhao Jinglong
Department of Oncology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Oncol Rep. 2022 Oct;48(4). doi: 10.3892/or.2022.8394. Epub 2022 Aug 31.
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that various panels showing data from flow cytometric experiments in Figs. 2D and 5D were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere when it was submitted to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 38: 3187‑3196, 2017; DOI: 10.3892/or.2017.5997].
在本文发表后,一位关注此事的读者提醒编辑注意,图2D和5D中显示流式细胞术实验数据的各个面板与不同作者在其他文章中以不同形式出现的数据惊人地相似。由于上述文章中存在争议的数据在提交给[期刊名称]时已在其他地方被考虑发表或已发表,编辑决定从该期刊撤回本文。已要求作者对这些问题作出解释,但编辑部未收到答复。编辑就由此造成的不便向读者表示歉意。[《肿瘤学报告》38: 3187 - 3196,2017;DOI: 10.3892/or.2017.5997]